Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian Cancers
Ovarian cancer (OvCa) is a destructive malignancy due to difficulties in early detection and late advanced-stage diagnoses, leading to high morbidity and mortality rates for women. Currently, the quality treatment for OvCa includes tumor debulking surgery and intravenous platinum-based chemotherapy....
Main Authors: | Melayshia McFadden, Santosh Kumar Singh, Gabriela Oprea-Ilies, Rajesh Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/21/5480 |
Similar Items
-
The effect of paclitaxel- and fisetin-loaded PBM nanoparticles on apoptosis and reversal of drug resistance gene ABCG2 in ovarian cancer
by: Melayshia McFadden, et al.
Published: (2023-11-01) -
Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery
by: Saquib Waheed, et al.
Published: (2022-08-01) -
The state-of-art polyurethane nanoparticles for drug delivery applications
by: Wencong Song, et al.
Published: (2024-02-01) -
Nano-based drug delivery systems: Conventional drug delivery routes, recent developments and future prospects
by: Afreen Sultana, et al.
Published: (2022-09-01) -
Development of nanoparticle‐based drug delivery system for inflammation treatment and diagnosis
by: Qin Qin, et al.
Published: (2023-12-01)